Overview

This trial is active, not recruiting.

Condition decision making
Treatment medication monitor
Sponsor University of Utah
Collaborator National Institutes of Health (NIH)
Start date July 2003
End date October 2013
Trial size 200 participants
Trial identifier NCT00715507, 1 R43 GM066615-01A2, 10599

Summary

To assess the clinical utility of the graphical medication monitor, results of the anesthetics for which the display was present will be compared to the results of the anesthetics in which there was no display.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Time perspective prospective
Arm
For the phase of the study in which the utility of the graphical medication monitor is assessed, the monitor will not be shown to anesthesiologists placed in the control condition.
In the experimental condition, anesthesiologists will be shown the medication monitor to aid their expertise and decision-making.
medication monitor
the medication monitor will aid in expertise and decision-making.

Primary Outcomes

Measure
assess differences between medication administration data and patient information with and without the use of the graphical medication monitor.
time frame: preoperative, intraoperative and postoperative

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Board certified attending anesthesiologists at the University of Utah Health Sciences Center and supervised anesthesiology residents and have been trained on the graphic display Exclusion Criteria: - Board certified attending anesthesiologists at the University of Utah Health Sciences Center and supervised anesthesiology residents that have not been trained on the graphic display

Additional Information

Official title Evaluation of Drug Display in Critical Care Setting
Principal investigator Ken Johnson
Description This study has two objectives: First, before the medication monitor is shown to anesthesiologists in a clinical setting, the PKPD models must be validated to assess the clinical reliability of the model-based predictions for patients undergoing general anesthesia. Second, once the PKPD models have been successfully validated, presenting it to anesthesiologists during administration of anesthesia will assess the impact of the graphical medication monitor. Differences in performance and patient care will be determined by comparing anesthesiologists who are presented with the monitor to those who care for patients without the monitor.
Trial information was received from ClinicalTrials.gov and was last updated in June 2012.
Information provided to ClinicalTrials.gov by University of Utah.